Top compounds associated with response to CDC16

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.0097	0.8
mRNA	lenvatinib	CTRPv2	pan-cancer	AAC	0.011	0.8
mRNA	BRD-K51831558	CTRPv2	pan-cancer	AAC	0.016	0.8
mRNA	KHS101	CTRPv2	pan-cancer	AAC	-0.011	0.8
mRNA	tivozanib	CTRPv2	pan-cancer	AAC	0.011	0.8
mRNA	GSK-J4	CTRPv2	pan-cancer	AAC	0.03	0.8
mRNA	EHT 1864	GDSC1000	pan-cancer	AAC	-0.0098	0.8
mRNA	CCT007093	GDSC1000	pan-cancer	AAC	0.0098	0.8
mRNA	Bortezomib	CTRPv2	pan-cancer	AAC	-0.01	0.8
mRNA	vorinostat:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.01	0.8

Download CSV